Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

April 27, 2017

MSF is bringing individual investors’ voices to Pfizer’s annual general meeting today in New Jersey.

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.
March 02, 2017

Key House subcommittee examined bill today that amends neglected disease innovation incentive program without fixing loopholes abused by pharmaceutical corporations

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

January 28, 2017

NEW YORK, JANUARY 28, 2017—President Donald J. Trump’s executive order suspending refugee resettlement to the United States is an inhumane act against people fleeing war zones, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, calling for a resumption of refugee resettlement.

January 25, 2017

NEW YORK, JANUARY 25, 2017—The reinstatement of the US government’s Mexico City Policy by President Donald J. Trump, which prohibits nongovernmental organizations that receive US funding from either performing or providing counseling or information on abortion, will undermine access to safe abortion services and endanger the lives of women, said Doctors Without Borders/Médecins Sans Frontières (MSF) Wednesday.

January 24, 2017

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability

December 20, 2016

NEW YORK, DECEMBER 20, 2016—After 14 years of Chagas diagnoses, treatment and prevention efforts in Bolivia, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) ended its Chagas operations today by presenting Bolivia’s Ministry of Health with an operating manual for managing Chagas disease in rural areas.

Pages